Manufacturers Wait Anxiously for CMS Decision on Automatic Medicare Coverage of MCIT Breakthrough Devices by Glenn S. Demby | Jul 1, 2021 | Articles, CMS-lir, Essential, FDA-lir, Laboratory Industry Report... This content is for Paid Members only.Login Register
Newly Reintroduced VITAL Act Would Strip Agency of LDT Regulatory Authority by Glenn S. Demby | Jun 14, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet... This content is for Paid Members only.Login Register
Manufacturers Wait Anxiously for CMS Decision on Automatic Medicare Coverage of MCIT Breakthrough Devices by Glenn S. Demby | Jun 8, 2021 | Articles, CMS-lir, Essential, FDA-lir, Laboratory Industry Report, LDTs-lir, Must read... This content is for Paid Members only.Login Register
AACC Guidelines Caution Against Using Serology Tests to Determine COVID-19 Vaccine Efficacy by Glenn S. Demby | May 22, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, Must read... This content is for Paid Members only.Login Register
Agency Streamlines Authorization of COVID-19 Molecular Test Pooling for Screening Programs by Glenn S. Demby | May 19, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet... This content is for Paid Members only.Login Register